Back to search
FDAFDA · Food and drugs·Recall number D-0452-2023

Unguentine Original Maximum Strength Pain Relieving/Antiseptic Ointment (Camphor 3.0%, Phenol 2.5%, Tannic Acid 2.2%, Oxide 6.6%), packaged in 1 oz. (28.3g) metal tubes, Distributed by: Oakhurst Company Levittown, NY 11756

Published March 15, 2023 · Recall initiated: February 24, 2023

Summary

FDA records drug Class II recall D-0452-2023, published March 15, 2023 and initiated February 24, 2023. Recalling firm: Ecometics, Inc.; Status: Terminated; Lot: Lot #: 1E346A, Exp. Date Nov-23; 2E304A, Exp. Date Oct-24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP DEVIATIONS

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ecometics, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 1E346A, Exp. Date Nov-23; 2E304A, Exp. Date Oct-24
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Unguentine Original Maximum Strength Pain Relieving/Antiseptic Ointment (Camphor 3.0%, Phenol 2.5%, Tannic Acid 2.2%, Oxide 6.6%), packaged in 1 oz. (28.3g) metal tubes, Distributed by: Oakhurst Company Levittown, NY 11756 recalled?

Yes. FDA published recall D-0452-2023 on March 15, 2023. Reported hazard: CGMP DEVIATIONS

What should I do if I have this product?

Voluntary: Firm initiated · Letter